{"id":9055,"date":"2019-08-19T12:17:30","date_gmt":"2019-08-19T09:17:30","guid":{"rendered":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/"},"modified":"2019-08-19T12:17:31","modified_gmt":"2019-08-19T09:17:31","slug":"pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico","status":"publish","type":"post","link":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/","title":{"rendered":"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico"},"content":{"rendered":"<p> [ad_1]<\/p>\n<div id=\"CuerpoNoticia\" itemprop=\"articleBody\">\n<p>MADRID, 19 Ago. (EUROPA PRESS) &#8211; <\/p>\n<p itemprop=\"description\">   La Agencia de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en ingl\u00e9s) ha aceptado la propuesta de PharmaMar de presentar, mediante un proceso de aprobaci\u00f3n acelerada, una solicitud de registro de un nuevo f\u00e1rmaco para el tratamiento de c\u00e1ncer de pulm\u00f3n microc\u00edtico en segunda l\u00ednea.<\/p>\n<p>   Seg\u00fan ha explicado este lunes la farmac\u00e9utica a la Comisi\u00f3n Nacional del Mercado de Valores (CNMV), el procedimiento de aprobaci\u00f3n de la FDA permite la presentaci\u00f3n de un dossier de registro para su evaluaci\u00f3n, basado en los resultados de los medicamentos en investigaci\u00f3n en fase II para el tratamiento de enfermedades graves y que adem\u00e1s cubran una necesidad m\u00e9dica.<\/p>\n<p>   La solicitud de registro de este nuevo f\u00e1rmaco se basar\u00e1 en los datos del ensayo de fase II con lurbinectedina, en monoterapia, para el tratamiento de c\u00e1ncer de pulm\u00f3n microc\u00edtico, que reclut\u00f3 105 pacientes en 39 centros de m\u00e1s de nueve pa\u00edses de Europa Occidental y Estados Unidos.<\/p>\n<p>   PharmaMar ha destacado que el ensayo cumpli\u00f3 su objetivo primario de la Tasa de Respuesta Global (ORR). Los objetivos secundarios incluyeron la Duraci\u00f3n de la Respuesta (DOR), la Supervivencia Libre de Progresi\u00f3n (PFS), la Supervivencia Global (OS) y la seguridad.<\/p>\n<p>   La farmac\u00e9utica prev\u00e9 presentar la solicitud de registro de este nuevo f\u00e1rmaco durante el cuarto trimestre de este a\u00f1o.<\/p>\n<\/div>\n<p>[ad_2]<br \/>\n<br \/><a href=\"https:\/\/www.europapress.es\/economia\/noticia-pharmamar-solicitara-eeuu-registro-nuevo-farmaco-contra-cancer-pulmon-microcitico-20190819084126.html\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[ad_1] MADRID, 19 Ago. (EUROPA PRESS) &#8211; La Agencia de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en ingl\u00e9s) ha aceptado la propuesta de PharmaMar de presentar, mediante un proceso de aprobaci\u00f3n acelerada, una solicitud de registro de un nuevo f\u00e1rmaco para el tratamiento de c\u00e1ncer de pulm\u00f3n microc\u00edtico en segunda l\u00ednea. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":9056,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9055","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-financieras"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico - Super News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico - Super News\" \/>\n<meta property=\"og:description\" content=\"[ad_1] MADRID, 19 Ago. (EUROPA PRESS) &#8211; La Agencia de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en ingl\u00e9s) ha aceptado la propuesta de PharmaMar de presentar, mediante un proceso de aprobaci\u00f3n acelerada, una solicitud de registro de un nuevo f\u00e1rmaco para el tratamiento de c\u00e1ncer de pulm\u00f3n microc\u00edtico en segunda l\u00ednea. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/\" \/>\n<meta property=\"og:site_name\" content=\"Super News\" \/>\n<meta property=\"article:published_time\" content=\"2019-08-19T09:17:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-08-19T09:17:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/super-news.info\/es\/wp-content\/uploads\/sites\/4\/2019\/08\/PharmaMar-solicitar-en-EEUU-el-registro-de-un-nuevo-f-rmaco.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"120\" \/>\n\t<meta property=\"og:image:height\" content=\"69\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"super-news\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"super-news\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/\"},\"author\":{\"name\":\"super-news\",\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/#\\\/schema\\\/person\\\/2d4068cb2f39cd10008c2fce578a7356\"},\"headline\":\"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico\",\"datePublished\":\"2019-08-19T09:17:30+00:00\",\"dateModified\":\"2019-08-19T09:17:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/\"},\"wordCount\":268,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/super-news.info\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2019\\\/08\\\/PharmaMar-solicitar-en-EEUU-el-registro-de-un-nuevo-f-rmaco.jpg\",\"articleSection\":[\"NOTICIAS FINANCIERAS\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/\",\"url\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/\",\"name\":\"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico - Super News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/super-news.info\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2019\\\/08\\\/PharmaMar-solicitar-en-EEUU-el-registro-de-un-nuevo-f-rmaco.jpg\",\"datePublished\":\"2019-08-19T09:17:30+00:00\",\"dateModified\":\"2019-08-19T09:17:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/#\\\/schema\\\/person\\\/2d4068cb2f39cd10008c2fce578a7356\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/#primaryimage\",\"url\":\"https:\\\/\\\/super-news.info\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2019\\\/08\\\/PharmaMar-solicitar-en-EEUU-el-registro-de-un-nuevo-f-rmaco.jpg\",\"contentUrl\":\"https:\\\/\\\/super-news.info\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2019\\\/08\\\/PharmaMar-solicitar-en-EEUU-el-registro-de-un-nuevo-f-rmaco.jpg\",\"width\":120,\"height\":69,\"caption\":\"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0413\u043b\u0430\u0432\u043d\u0430\u044f \u0441\u0442\u0440\u0430\u043d\u0438\u0446\u0430\",\"item\":\"https:\\\/\\\/super-news.info\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/super-news.info\\\/es\\\/\",\"name\":\"Super News\",\"description\":\"Super News Espa\u00f1a\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/super-news.info\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/super-news.info\\\/es\\\/#\\\/schema\\\/person\\\/2d4068cb2f39cd10008c2fce578a7356\",\"name\":\"super-news\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/64ebac40b93f26a154f8a9b5b6fdccfc46f442b26b3dd6756dbff3bf9dc76fd7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/64ebac40b93f26a154f8a9b5b6fdccfc46f442b26b3dd6756dbff3bf9dc76fd7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/64ebac40b93f26a154f8a9b5b6fdccfc46f442b26b3dd6756dbff3bf9dc76fd7?s=96&d=mm&r=g\",\"caption\":\"super-news\"},\"url\":\"https:\\\/\\\/super-news.info\\\/es\\\/author\\\/pt\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico - Super News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/","og_locale":"en_US","og_type":"article","og_title":"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico - Super News","og_description":"[ad_1] MADRID, 19 Ago. (EUROPA PRESS) &#8211; La Agencia de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en ingl\u00e9s) ha aceptado la propuesta de PharmaMar de presentar, mediante un proceso de aprobaci\u00f3n acelerada, una solicitud de registro de un nuevo f\u00e1rmaco para el tratamiento de c\u00e1ncer de pulm\u00f3n microc\u00edtico en segunda l\u00ednea. [&hellip;]","og_url":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/","og_site_name":"Super News","article_published_time":"2019-08-19T09:17:30+00:00","article_modified_time":"2019-08-19T09:17:31+00:00","og_image":[{"width":120,"height":69,"url":"https:\/\/super-news.info\/es\/wp-content\/uploads\/sites\/4\/2019\/08\/PharmaMar-solicitar-en-EEUU-el-registro-de-un-nuevo-f-rmaco.jpg","type":"image\/jpeg"}],"author":"super-news","twitter_card":"summary_large_image","twitter_misc":{"Written by":"super-news","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/#article","isPartOf":{"@id":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/"},"author":{"name":"super-news","@id":"https:\/\/super-news.info\/es\/#\/schema\/person\/2d4068cb2f39cd10008c2fce578a7356"},"headline":"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico","datePublished":"2019-08-19T09:17:30+00:00","dateModified":"2019-08-19T09:17:31+00:00","mainEntityOfPage":{"@id":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/"},"wordCount":268,"commentCount":0,"image":{"@id":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/#primaryimage"},"thumbnailUrl":"https:\/\/super-news.info\/es\/wp-content\/uploads\/sites\/4\/2019\/08\/PharmaMar-solicitar-en-EEUU-el-registro-de-un-nuevo-f-rmaco.jpg","articleSection":["NOTICIAS FINANCIERAS"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/","url":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/","name":"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico - Super News","isPartOf":{"@id":"https:\/\/super-news.info\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/#primaryimage"},"image":{"@id":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/#primaryimage"},"thumbnailUrl":"https:\/\/super-news.info\/es\/wp-content\/uploads\/sites\/4\/2019\/08\/PharmaMar-solicitar-en-EEUU-el-registro-de-un-nuevo-f-rmaco.jpg","datePublished":"2019-08-19T09:17:30+00:00","dateModified":"2019-08-19T09:17:31+00:00","author":{"@id":"https:\/\/super-news.info\/es\/#\/schema\/person\/2d4068cb2f39cd10008c2fce578a7356"},"breadcrumb":{"@id":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/#primaryimage","url":"https:\/\/super-news.info\/es\/wp-content\/uploads\/sites\/4\/2019\/08\/PharmaMar-solicitar-en-EEUU-el-registro-de-un-nuevo-f-rmaco.jpg","contentUrl":"https:\/\/super-news.info\/es\/wp-content\/uploads\/sites\/4\/2019\/08\/PharmaMar-solicitar-en-EEUU-el-registro-de-un-nuevo-f-rmaco.jpg","width":120,"height":69,"caption":"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico"},{"@type":"BreadcrumbList","@id":"https:\/\/super-news.info\/es\/pharmamar-solicitara-en-eeuu-el-registro-de-un-nuevo-farmaco-contra-el-cancer-de-pulmon-microcitico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0413\u043b\u0430\u0432\u043d\u0430\u044f \u0441\u0442\u0440\u0430\u043d\u0438\u0446\u0430","item":"https:\/\/super-news.info\/es\/"},{"@type":"ListItem","position":2,"name":"PharmaMar solicitar\u00e1 en EEUU el registro de un nuevo f\u00e1rmaco contra el c\u00e1ncer de pulm\u00f3n microc\u00edtico"}]},{"@type":"WebSite","@id":"https:\/\/super-news.info\/es\/#website","url":"https:\/\/super-news.info\/es\/","name":"Super News","description":"Super News Espa\u00f1a","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/super-news.info\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/super-news.info\/es\/#\/schema\/person\/2d4068cb2f39cd10008c2fce578a7356","name":"super-news","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/64ebac40b93f26a154f8a9b5b6fdccfc46f442b26b3dd6756dbff3bf9dc76fd7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/64ebac40b93f26a154f8a9b5b6fdccfc46f442b26b3dd6756dbff3bf9dc76fd7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/64ebac40b93f26a154f8a9b5b6fdccfc46f442b26b3dd6756dbff3bf9dc76fd7?s=96&d=mm&r=g","caption":"super-news"},"url":"https:\/\/super-news.info\/es\/author\/pt\/"}]}},"_links":{"self":[{"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/posts\/9055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/comments?post=9055"}],"version-history":[{"count":1,"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/posts\/9055\/revisions"}],"predecessor-version":[{"id":9057,"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/posts\/9055\/revisions\/9057"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/media\/9056"}],"wp:attachment":[{"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/media?parent=9055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/categories?post=9055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/super-news.info\/es\/wp-json\/wp\/v2\/tags?post=9055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}